Pursuant to Regulation 34(1)(a) and clause 12 of Part A of Schedule III read with Regulation 3 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zenotech Laboratories has submitted the Annual Report for the financial year 2020-21 along with the Notice of the 32nd Annual General Meeting of the Company, scheduled to be held on Saturday, September 25, 2021 at 10.30 am IST (Indian Standard Time) through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM), a copy of which was e-mailed to all the shareholders of the Company whose e-mail ids are available with them. The remote e-voting period shall commence on Wednesday, September 22, 2021 at 09:00 am and shall end on Friday, September 24, 2021 at 05:00 pm. The business proposed to be transacted at the 32nd Annual General Meeting, as detailed in the notice is attached.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.45 |
| Dr. Reddys Lab | 1223.65 |
| Cipla | 1230.25 |
| Zydus Lifesciences | 929.45 |
| Lupin | 2335.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: